Ratiopharm competitive analysis

Explore patent oppositions filed by Ratiopharm against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTFeb 26, 2025
Method Of Providing Pirfenidone Therapy To A PatientINTERMUNEDec 15, 2016
Modifying Pirfenidone Treatment For Patients With Atypical Liver FunctionINTERMUNEDec 15, 2016
Methods Of Reducing Adverse Events Associated With Pirfenidone TherapyINTERMUNESep 8, 2016

Explore Ratiopharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Sep 3, 2025Pharmaceutical Formulation Comprising Ezetimibe3
Oct 4, 2017Crystalline Salts Of Sitagliptin1
Jul 19, 2017Pharmaceutical Formulation Comprising Ezetimibe6
Dec 28, 2016Solid Pharmaceutical Composition Comprising A Non-Peptide Angiotensin Ii Receptor Antagonist And A Diuretic1
Sep 23, 2015Solid Pharmaceutical Dosage Form9
Aug 12, 2015Solid Pharmaceutical Dosage Form Of Ticagrelor And Acetylsalicylic Acid3
Mar 25, 2015Oral Dispersible Tablet1
May 14, 2014Oral Dosage Forms For Modified Release Comprising Tasocitinib2

Latest PTAB cases involving Ratiopharm

Discover the latest PTAB cases involving Ratiopharm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ratiopharm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
RATIOPHARM424 - -
GALENICUM HEALTH SLU4212 - -
GENERICS UK TRADING MYLAN48 - - -
INTERMUNE - 27 - -